#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paroxysmal nocturnal haemoglobinuria Stevens-Johnson syndrome Rhabdomyosarcoma Short stature Ocular lymphoma Exudative retinopathy Chronic granulomatous disease Congenital absence of bile ducts Rhabdomyosarcoma recurrent Thyroid cancer metastatic Angelman's syndrome Plasma cell myeloma recurrent Extraskeletal ossification Cataract Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Trials in Disease Hereditary hypophosphataemic rickets – Trials in Disease Arterial tortuosity syndrome – Treatment Hepatoblastoma – Diagnostics Ewing’s sarcoma Haemophilia B without inhibitors – Trials in Disease Waldenstrom’s macroglobulinaemia – Treatment KBG syndrome – Basic Information Fragile X syndrome Nodal marginal zone B-cell lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sacituzumab Govitecan Danicopan Neratinib Diclofenac Prs-344 Febuxostat Abt-494 Human Cancellous Bone Sodium Valproate Cellulose, Microcrystalline Ht-29-B Tilmanocept VX-407 Caffeine Human Albumin Solution Teverelix Buprenorphine Diltiazem ALG-000184 Milademetan More therapies…

    Learn about Your Condition

    Autoimmune uveitis Hypochromic anaemia Seizure MELAS syndrome Paraesthesia Metachromatic leukodystrophy Malignant melanoma stage II Osteogenesis imperfecta Intestinal obstruction Fibrosarcoma Congenital ureteric anomaly Paget's disease of the vulva Rhinitis allergic Pulmonary fibrosis Peritonitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Sofiamed OOD

Ulitsa Dimitir Mollov 10, Sofia, 1750, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Croatia Hungary Poland Romania

  • Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

    Recruiting

    2 1
    Investigated Drugs:
    • Namodenoson
    Bulgaria Poland Romania

  • Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    • Obesity
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Cachexia
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Ponsegromab
    Belgium Bulgaria France Germany Italy Poland +2

  • Study of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Atezolizumab
    • Lenvatinib
    Austria Belgium Bulgaria Croatia Estonia Finland +6

  • A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight

    Not recruiting

    3 1
    Investigated Drugs:
    • Maridebart Cafraglutide
    Bulgaria Czechia Germany Hungary Italy Poland

  • Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Acasunlimab
    • Anakinra
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Croatia Estonia France +9

  • Study on Fentanyl Nasal Spray and Morphine for Managing Postoperative Pain in Patients After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fentanyl Citrate
    • Placebo
    Bulgaria Germany
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!